Effects of chronic AICAR treatment on fiber composition, enzyme activity, UCP3, and PGC-1 in rat muscles.
about
The NR4A subgroup: immediate early response genes with pleiotropic physiological rolesAMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activityAMP-activated protein kinase, stress responses and cardiovascular diseasesPeroxisome proliferator-activated receptor gamma coactivator 1alpha or 1beta overexpression inhibits muscle protein degradation, induction of ubiquitin ligases, and disuse atrophySkeletal muscle-selective knockout of LKB1 increases insulin sensitivity, improves glucose homeostasis, and decreases TRB3Hydroxycinnamic acid derivatives: a potential class of natural compounds for the management of lipid metabolism and obesityPostnatal muscle modification by myogenic factors modulates neuropathology and survival in an ALS mouse modelAMP-activated protein kinase plays an important evolutionary conserved role in the regulation of glucose metabolism in fish skeletal muscle cellsShort-term caloric restriction, resveratrol, or combined treatment regimens initiated in late-life alter mitochondrial protein expression profiles in a fiber-type specific manner in aged animalsEpinephrine and AICAR-induced PGC-1α mRNA expression is intact in skeletal muscle from rats fed a high-fat dietMetformin and exercise reduce muscle FAT/CD36 and lipid accumulation and blunt the progression of high-fat diet-induced hyperglycemiaAMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1alphaAcute or chronic upregulation of mitochondrial fatty acid oxidation has no net effect on whole-body energy expenditure or adiposity.AMP-activated protein kinase-regulated activation of the PGC-1alpha promoter in skeletal muscle cells.Exercise-induced skeletal muscle remodeling and metabolic adaptation: redox signaling and role of autophagy.Impact of Aging and Exercise on Mitochondrial Quality Control in Skeletal Muscle.Signaling mechanisms in skeletal muscle: acute responses and chronic adaptations to exercise.Early combined treatment with sildenafil and adipose-derived mesenchymal stem cells preserves heart function in rat dilated cardiomyopathyAMP kinase and malonyl-CoA: targets for therapy of the metabolic syndrome.Endurance training increases skeletal muscle LKB1 and PGC-1alpha protein abundance: effects of time and intensity.The Pim protein kinases regulate energy metabolism and cell growthBerberine improves lipid dysregulation in obesity by controlling central and peripheral AMPK activity.Effect of LKB1 deficiency on mitochondrial content, fibre type and muscle performance in the mouse diaphragm.AICAR inhibits adipocyte differentiation in 3T3L1 and restores metabolic alterations in diet-induced obesity mice modelKLF15 is a molecular link between endoplasmic reticulum stress and insulin resistance.Excitation-transcription coupling in skeletal muscle: the molecular pathways of exercise.A fundamental system of cellular energy homeostasis regulated by PGC-1alphaSmall interfering RNA targeting PGC-1α inhibits VEGF expression and tube formation in human retinal vascular endothelial cells.AMPK activation with glabridin ameliorates adiposity and lipid dysregulation in obesity.Combined activation of the energy and cellular-defense pathways may explain the potent anti-senescence activity of methylene blue.The regulation of mitochondrial transcription factor A (Tfam) expression during skeletal muscle cell differentiation.Combinatorial therapeutic activation with heparin and AICAR stimulates additive effects on utrophin A expression in dystrophic muscles.Orphan nuclear receptors: therapeutic opportunities in skeletal muscle.Energy sensing and regulation of gene expression in skeletal muscle.AMP-activated protein kinase and its downstream transcriptional pathwaysResveratrol alleviates alcoholic fatty liver in mice.Comparing and contrasting the roles of AMPK and SIRT1 in metabolic tissues.Butyrate improves insulin sensitivity and increases energy expenditure in miceElectroacupuncture in the treatment of obesity.PGC-1 coactivators and skeletal muscle adaptations in health and disease.
P2860
Q24540372-29A8031F-E9E3-49D7-B7E8-D49F53C2E1E8Q24595845-ED0D5720-29D6-4F8E-B0FE-6342D5CF98EFQ24610297-27F5D140-5E02-4C23-ABA3-3AB23DDB9084Q24634396-965AF02C-E339-4B09-AB28-E382313C5E1CQ24672153-9C0648CD-A8F4-4A5A-AA12-0D8B16A178BDQ26749072-CB8BC949-88DF-462B-806B-E222746940B7Q27324722-AD2E1B28-0362-4390-9BAE-7F767D2AE698Q28480896-B2829181-74FB-4F5E-A6AA-17E23BEC3C2EQ28566837-7D9B0D44-30A2-4845-8B9B-AA8D8C7A92A2Q28567454-B7D336D4-1683-422D-B25D-33629CD42CDAQ28581219-75036CF4-4DC3-40C1-8159-517B370661FDQ29620443-2CED1E48-6849-4F86-89FB-4EC93E2113D2Q30433606-E55FC47E-104E-4335-9601-12F8C30E1CEDQ33381651-7FF506D9-EC14-459C-9D6E-AA803A6C15DFQ33722890-E17E4871-401F-4A1A-9B94-544AAE9B743FQ33800755-0F6862F5-B55A-46E1-8929-C3DAD528E2A9Q33913651-53016587-8DEA-4F9B-9183-0A45E9EE15FFQ34208448-B6C08C19-95D4-4C77-8F31-3F336151D8FDQ34310675-089D97BA-D372-496C-A1BA-8F73C745C66CQ34433480-B8A82883-BF14-4168-9AF8-76FCF8CC19CAQ34490450-04230A79-ABB1-4B88-A05E-D6F0A80CF590Q34603754-A0EAB816-2092-402F-BD51-487135DDB2A1Q34647665-C03EF73C-69CA-4D17-8CDA-C43C43D18DAEQ35024638-57AA2F88-29F9-42DE-A580-0D65CED23057Q35027785-195694AA-2571-43B3-AABC-45AA8C3DE564Q35207442-07EFAAB7-9667-4E2F-AD5A-947019B6488FQ35808821-71509E35-34B8-4DF5-A1EC-E23B6E2BF4BFQ35838292-8C5467A5-010B-4B42-BC6D-A6E1EC04BD66Q36020243-9F78B442-8EE2-46EE-840C-07116B558AB4Q36106343-6E4F74F0-3362-4C59-BE0F-05E3B627925AQ36185197-71AC9675-B1D5-4FA7-9152-3DA826FCBC50Q36402509-3446FCAA-9BD6-4D7C-BCDE-BBD8F6CBAE0AQ36529528-2B6019C5-12E8-4971-99AC-EE5BBF6DA8DDQ36643388-52665587-8DD0-40FE-9F26-43395163B690Q36756228-9FD95B6F-60B3-4F87-BADB-9BEB42C4EA20Q36956120-8E2A60A8-C8F8-4E19-9108-951B2F384F9CQ37024437-03F5031A-49A4-4EBD-AAB1-2777C2AD3679Q37236322-0869CFD2-B966-46F2-9E21-383EB3553E65Q37249417-B76B2BC1-75FC-4D99-9585-1473FEBE8647Q37265277-FB15B219-87F7-4D4D-A88A-C296F88F6E35
P2860
Effects of chronic AICAR treatment on fiber composition, enzyme activity, UCP3, and PGC-1 in rat muscles.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Effects of chronic AICAR treat ...... CP3, and PGC-1 in rat muscles.
@en
Effects of chronic AICAR treat ...... CP3, and PGC-1 in rat muscles.
@nl
type
label
Effects of chronic AICAR treat ...... CP3, and PGC-1 in rat muscles.
@en
Effects of chronic AICAR treat ...... CP3, and PGC-1 in rat muscles.
@nl
prefLabel
Effects of chronic AICAR treat ...... CP3, and PGC-1 in rat muscles.
@en
Effects of chronic AICAR treat ...... CP3, and PGC-1 in rat muscles.
@nl
P1476
Effects of chronic AICAR treat ...... UCP3, and PGC-1 in rat muscles
@en
P2093
Hiroshi Nakano
Shuzo Kumagai
P304
P356
10.1152/JAPPLPHYSIOL.00349.2003
P407
P577
2003-05-30T00:00:00Z